Propane
CAS 74-98-6
Propane (CAS 74-98-6) is a pharmaceutical compound with 0 bioactivity targets and 17 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| PROPANE | 1362877 | SU | MTHSPL |
| Propane | 1362877 | SU | MTHSPL |
| propane | 1362877 | SU | MTHSPL |
| propane | 1362877 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Propane used for in pharmaceutical contexts?
Propane (CAS 74-98-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Propane?
Propane has 17 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Cerebral atrophy, Drug abuse, Drug ineffective, Drug ineffective for unapproved indication, Dysaesthesia. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Propane also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Propane with EU status "permitted".
What clinical phase is Propane in?
No phase 1-4 clinical development badge is rendered for Propane because the matched compound identifier rows do not contain a max-phase value.